• FY25 revenue of $19.7 million, up 26% vs prior year
• Revenue growth across all key geographic regions: Europe +18%, North America +45%, APAC and ROW +33%
• Continued investment in sales team and distribution channels driving performance

CleanSpace Holdings Limited (ASX: CSX), a designer and manufacturer of respiratory protection equipment for industrial and healthcare solutions, has announced preliminary unaudited revenue results for the year ended 30 June 2025 (FY25). The company reported group revenue of $19.7 million, a 26% increase compared to the prior corresponding period (PCP). This strong sales performance continued into the second half of FY25, with H2 revenue also growing 26%. The company's focus on industrial markets has paid off, with the addition of new sales staff in key markets and the establishment of new third-party distribution agreements helping to drive underlying performance. CleanSpace saw robust revenue growth across all major geographic regions, with Europe up 18% versus the PCP, APAC and ROW up 33%, and North America delivering an impressive 45% increase. The company attributed the North American growth to the successful implementation of its industrial market strategy and the introduction of a new Regional Vice President and team in the United States. CleanSpace continues to invest in research and development, resulting in differentiated product designs and approved products that provide compelling benefits to employers and users. The company is also developing new and exciting applications to broaden the appeal of its products and open up significant new growth opportunities.

CleanSpace expects to report detailed, audited full year FY25 results on 26 August 2025.

As CleanSpace heads into FY26, the company has a very clear strategy for delivering continued strong growth for its shareholders.